Welcome to LookChem.com Sign In|Join Free
  • or
N-(5-phenylthiazol-2-yl)butyramide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

267654-13-7

Post Buying Request

267654-13-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

267654-13-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 267654-13-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,7,6,5 and 4 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 267654-13:
(8*2)+(7*6)+(6*7)+(5*6)+(4*5)+(3*4)+(2*1)+(1*3)=167
167 % 10 = 7
So 267654-13-7 is a valid CAS Registry Number.

267654-13-7Downstream Products

267654-13-7Relevant academic research and scientific papers

Identification of KPNB1 as a Cellular Target of Aminothiazole Derivatives with Anticancer Activity

Kim, Yong-Hak,Ha, Siyoung,Kim, Jungwon,Ham, Seung Wook

supporting information, p. 1406 - 1409 (2016/07/16)

We found that aminothiazole derivative (E)-N-(5-benzylthiazol-2-yl)-3-(furan-2-yl)acrylamide (1) has strong anticancer activity, and undertook proteomics approaches to identify the target protein of compound 1, importin β1 (KPNB1). A competitive binding assay using fluorescein-labeled 1 showed that 1 has strong binding affinity for KPNB1 (Kd: ~20 nm). Furthermore, through western blotting assays for KPNB1, KPNA2, EGFR, ErbB2, and STAT3, we confirmed that 1 has inhibitory effects on the importin pathway. KPBN1 appears to be overexpressed in several cancer cells, and siRNA-induced inhibition of KPNB1 shows significant inhibition of cancer cell proliferation, while leaving non-cancerous cells unaffected. Therefore, compound 1 is a promising new lead for the development of KPNB1-targeted anticancer agents. Fluorescein-labeled 1 could be a useful quantitative probe for the development of novel KPNB1 inhibitors.

Novel 2-Aminothiazole Derivatives and Composition for Treating Cancer Comprising the Same

-

Paragraph 0057; 0058; 0059; 0070, (2017/06/06)

PURPOSE: A novel 2-aminothiazole derivative and an anticancer composition containing the same are provided to suppress growth and proliferation of various cancer cells and to induce cancer cell apoptosis. CONSTITUTION: A 2-aminothiazole derivative is denoted by chemical formula 1. In chemical formula 1, R1 is phenyl, halogen-substituted phenyl, alkyl of 1-4 carbon atoms, or phenyl-substituted alkyl of C1-4; and R2 is alkyl of C1-9, furyl-substituted alkyl of C1-4, furyl-substituted alkenyl of C1-4. An anticancer composition contains the 2-aminothiazole derivative of chemical formula 1 or pharmaceutically acceptable salt thereof as an active ingredient. The anticancer composition is a pharmaceutical composition for preventing or treating cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 267654-13-7